OpenSourceMalaria:Compound Series: Difference between revisions
From OpenWetWare
Jump to navigationJump to search
Matthew Todd (talk | contribs) (Link to other possible series) |
Anthony Sama (talk | contribs) No edit summary |
||
| (5 intermediate revisions by 3 users not shown) | |||
| Line 3: | Line 3: | ||
A summary of progress in the OSM project may be found in the [[OpenSourceMalaria:Story_so_far|Story so Far]]. The pages below include the technical detail of the individual series examined and are written for scientific contributors. | A summary of progress in the OSM project may be found in the [[OpenSourceMalaria:Story_so_far|Story so Far]]. The pages below include the technical detail of the individual series examined and are written for scientific contributors. | ||
[[OpenSourceMalaria:GSK_Arylpyrrole_Series |'''Series 1: GSK Arylpyrroles''']] ( | [[OpenSourceMalaria:GSK_Arylpyrrole_Series |'''Series 1: GSK Arylpyrroles''']] (Paper has been released: http://pubs.acs.org/doi/full/10.1021/acscentsci.6b00086) | ||
[[OpenSourceMalaria:GSK_Triazolourea_Singleton |'''Series 2: GSK Triazoloureas''']] (parked) | [[OpenSourceMalaria:GSK_Triazolourea_Singleton |'''Series 2: GSK Triazoloureas''']] (parked) | ||
[[OpenSourceMalaria:GSK_Amino-thienopyrimidine_Series |'''Series 3: GSK Thienopyrimidines''']] ( | [[OpenSourceMalaria:GSK_Amino-thienopyrimidine_Series |'''Series 3: GSK Thienopyrimidines''']] (work is resuming) | ||
[[OpenSourceMalaria:Triazolopyrazine_(TP)_Series |'''Series 4: Triazolopyrazines ( | [[OpenSourceMalaria:Triazolopyrazine_(TP)_Series |'''Series 4: Triazolopyrazines (TP series)''']] (current priority) | ||
[[OpenSourceMalaria:Triazolopyrazine_Series Mechanism of Action |'''Series 4: Mechanism of Action''']] | |||
[[OpenSourceMalaria:Synthesis Branches |'''Synthetic Branches''']] | [[OpenSourceMalaria:Synthesis Branches |'''Synthetic Branches''']] | ||
Latest revision as of 11:24, 27 May 2017
A summary of progress in the OSM project may be found in the Story so Far. The pages below include the technical detail of the individual series examined and are written for scientific contributors.
Series 1: GSK Arylpyrroles (Paper has been released: http://pubs.acs.org/doi/full/10.1021/acscentsci.6b00086)
Series 2: GSK Triazoloureas (parked)
Series 3: GSK Thienopyrimidines (work is resuming)
Series 4: Triazolopyrazines (TP series) (current priority)
